×
About 573 results

ALLMedicine™ Anaplastic Oligodendroglioma Center

Research & Reviews  279 results

TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas...
https://doi.org/10.1002/onco.13765
The Oncologist; Tabouret E, Fabbro M et. al.

Mar 30th, 2021 - Treatment with temozolomide and BCNU was associated with substantial response and survival rates for patients with unresectable anaplastic glioma, suggesting potential therapeutic alternative for these patients. The optimal treatment for unresecta...

Prolonged benefit to pembrolizumab in anaplastic oligodendroglioma patient with mismatc...
https://doi.org/10.1097/CAD.0000000000001011
Anti-cancer Drugs; Padovan M, Caccese M et. al.

Jan 4th, 2021 - High-grade gliomas, including anaplastic oligodendroglioma, represent the most common malignant neoplasms of the central nervous system in the adult. The standard treatment of anaplastic oligodendroglioma consists of maximum surgical resection, ra...

Anaplastic Oligodendroglioma - Is Adjuvant Radiotherapy Mandatory following Maximal Sur...
https://doi.org/10.1016/j.clineuro.2020.106303
Clinical Neurology and Neurosurgery; Profyris C, Chen E et. al.

Oct 28th, 2020 - Current anaplastic oligodendroglioma (AO) management strategies involve surgical resection followed by adjuvant radiotherapy and/or chemotherapy. We investigated a subset of patients at our institution with AO, who, based on their treatment prefer...

Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodend...
https://doi.org/10.1007/s11523-020-00754-6
Targeted Oncology; Sepúlveda-Sánchez JM, Gil-Gil M et. al.

Oct 7th, 2020 - The cell cycle checkpoint G1/S, dependent on cyclin-dependent kinase (CDK) 4 amplification/overexpression and retinoblastoma phosphorylation, is altered in most anaplastic oligodendrogliomas (AOs). We aimed to evaluate the efficacy of palbociclib,...

Sustained response to erlotinib and rapamycin in a patient with pediatric anaplastic ol...
https://doi.org/10.1002/pbc.28750
Pediatric Blood & Cancer REFERENCES; Geben LC, Mobley BC et. al.

Oct 1st, 2020 - One goal of precision medicine is to identify mutations within individual tumors to design targeted treatment approaches. This report details the use of genomic testing to select a targeted therapy regimen of erlotinib and rapamycin for a pediatri...

see more →

Guidelines  2 results

Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics
https://diagnosticpathology.biomedcentral.com/articles/10.1186/s13000-019-0793-5
Romo,C.,et al

Feb 8th, 2019 - We present the case of a 28-year-old man with an IDH1 and TP53 mutant high grade glioma with abnormalities in chromosomes 1 and 19 suggestive of anaplastic oligodendroglioma that rapidly progressed to widespread metastatic disease. Biopsy of a liv...

Central nervous system cancers.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124889
Journal of the National Comprehensive Cancer Network : JN... Nabors LB, Ammirati M et. al.

Sep 13th, 2013 - Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemothera...

see more →

Clinicaltrials.gov  289 results

TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas...
https://doi.org/10.1002/onco.13765
The Oncologist; Tabouret E, Fabbro M et. al.

Mar 30th, 2021 - Treatment with temozolomide and BCNU was associated with substantial response and survival rates for patients with unresectable anaplastic glioma, suggesting potential therapeutic alternative for these patients. The optimal treatment for unresecta...

Prolonged benefit to pembrolizumab in anaplastic oligodendroglioma patient with mismatc...
https://doi.org/10.1097/CAD.0000000000001011
Anti-cancer Drugs; Padovan M, Caccese M et. al.

Jan 4th, 2021 - High-grade gliomas, including anaplastic oligodendroglioma, represent the most common malignant neoplasms of the central nervous system in the adult. The standard treatment of anaplastic oligodendroglioma consists of maximum surgical resection, ra...

Anaplastic Oligodendroglioma - Is Adjuvant Radiotherapy Mandatory following Maximal Sur...
https://doi.org/10.1016/j.clineuro.2020.106303
Clinical Neurology and Neurosurgery; Profyris C, Chen E et. al.

Oct 28th, 2020 - Current anaplastic oligodendroglioma (AO) management strategies involve surgical resection followed by adjuvant radiotherapy and/or chemotherapy. We investigated a subset of patients at our institution with AO, who, based on their treatment prefer...

Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodend...
https://doi.org/10.1007/s11523-020-00754-6
Targeted Oncology; Sepúlveda-Sánchez JM, Gil-Gil M et. al.

Oct 7th, 2020 - The cell cycle checkpoint G1/S, dependent on cyclin-dependent kinase (CDK) 4 amplification/overexpression and retinoblastoma phosphorylation, is altered in most anaplastic oligodendrogliomas (AOs). We aimed to evaluate the efficacy of palbociclib,...

Sustained response to erlotinib and rapamycin in a patient with pediatric anaplastic ol...
https://doi.org/10.1002/pbc.28750
Pediatric Blood & Cancer REFERENCES; Geben LC, Mobley BC et. al.

Oct 1st, 2020 - One goal of precision medicine is to identify mutations within individual tumors to design targeted treatment approaches. This report details the use of genomic testing to select a targeted therapy regimen of erlotinib and rapamycin for a pediatri...

see more →

News  3 results

Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics
https://diagnosticpathology.biomedcentral.com/articles/10.1186/s13000-019-0793-5
Romo,C.,et al

Feb 8th, 2019 - We present the case of a 28-year-old man with an IDH1 and TP53 mutant high grade glioma with abnormalities in chromosomes 1 and 19 suggestive of anaplastic oligodendroglioma that rapidly progressed to widespread metastatic disease. Biopsy of a liv...

Thunderclap Headache Associated With a Nonhemorrhagic Anaplastic Oligodendroglioma
https://www.medscape.com/viewarticle/559493_2

Discussion Although Day and Raskin[1] initially coined the term thunderclap headache to refer to the headache associated with an unruptured aneurysm, the most common secondary cause is subarachnoid hemorrhage. Other secondary causes include cerebr...

Thunderclap Headache Associated With a Nonhemorrhagic Anaplastic Oligodendroglioma
https://www.medscape.com/viewarticle/559493

Case Report A thunderclap headache is a severe headache with sudden onset similar to a clap of thunder, with a maximum intensity within 1 minute. The primary types (thunderclap, cough, exertional, and sexual) can recur intermittently and are gener...

see more →